Clinical trial · Observational
Living Donor Liver Transplantation in Children
Living Donor Liver Transplantation in Children: Surgical and Immunological Results in 250 Recipients at Université Catholique de Louvain.
NCT02124382CI-TRIAL-00014351completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluate the outcome of pediatric living donor liver transplantation (LDLT) regarding portal vein reconstruction, ABO-compatibility and impact of maternal donation on graft acceptance.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Healthy Donors | — | UNRESOLVED | — |
| Pediatric Liver Transplanted Recipients | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Patient and graft survival
- timeFrame
- 10 years
- description
- Kaplan-Meier
Secondary outcomes (1)
- measure
- Portal vein complications
- timeFrame
- 10 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 57 Years
Show eligibility criteria text
Inclusion Criteria: * Children receiving a living donor liver transplant * Adult living donors Exclusion Criteria: * No one
References
Publications (0)
Data not yet available
No reference posted for this study.